LongeVC

LongeVC LongeVC is a longevity-focused biotech VC founded in 2020. Fund I raised $25M, backed 20 portfolio companies, achieved 3x+ MOIC, and placed in the top quartile. with zero write-offs. Fund II is now targeting $120M with a $2M minimum LP commitment. The focus is regenerative medicine, AI-driven drug discovery, and age-related diseases spanning cancer, neurodegeneration, metabolic disorders, and cardiovascular conditions. The portfolio includes Deep Longevity, Rubedo Life Sciences, and AOA